Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.9%

18 terminated/withdrawn out of 151 trials

Success Rate

86.4%

-0.1% vs industry average

Late-Stage Pipeline

12%

18 trials in Phase 3/4

Results Transparency

63%

72 of 114 completed trials have results

Key Signals

7 recruiting72 with results15 terminated

Enrollment Performance

Analytics

Phase 2

42(35.6%)

Phase 1

40(33.9%)

N/A

16(13.6%)

Phase 3

14(11.9%)

Phase 4

4(3.4%)

Early Phase 1

2(1.7%)

118Total

Phase 2(42)

Phase 1(40)

N/A(16)

Phase 3(14)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (151)

Showing 20 of 151 trials

NCT03407638Not ApplicableCompleted

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Role: collaborator

NCT07631598Not ApplicableNot Yet Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Role: collaborator

NCT03918850Phase 3Completed

Medication Treatment for Opioid Use Disorder in Expectant Mothers

Role: collaborator

NCT04139304Early Phase 1Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Role: collaborator

NCT02799485Phase 2Completed

sEphB4-HSA in Treating Patients With Kaposi Sarcoma

Role: collaborator

NCT05938465Phase 1Recruiting

Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)

Role: collaborator

NCT06494904Phase 3Recruiting

Standard Versus High Dose ED-Initiated Buprenorphine Induction

Role: collaborator

NCT07475728Not Yet Recruiting

EMS-Initiated Buprenorphine

Role: collaborator

NCT07510048Phase 2Not Yet Recruiting

Combatting HIV Or Other STIs Early (CHOOSE)

Role: collaborator

NCT03603808Phase 2Completed

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Role: collaborator

NCT06323824Phase 4Recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Role: collaborator

NCT03427736Recruiting

Anesthetics and Analgesics in Children

Role: collaborator

NCT06023459Phase 3Completed

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

Role: collaborator

NCT03511118Recruiting

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Role: collaborator

NCT04921787Not ApplicableActive Not Recruiting

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

Role: collaborator

NCT03866174Phase 2Completed

A Study of Psilocybin for Major Depressive Disorder (MDD)

Role: collaborator

NCT02437851Phase 2Completed

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Role: collaborator

NCT06042257Phase 2Terminated

Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)

Role: collaborator

NCT07438041Not ApplicableNot Yet Recruiting

Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services

Role: collaborator

NCT03601806Phase 2Completed

Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

Role: collaborator